Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T60472 |
GSK-3β inhibitor 12
|
GSK-3 | PI3K/Akt/mTOR signaling; Stem Cells |
GSK-3β inhibitor 12 是一种选择性 GSK-3β 的抑制剂。GSK-3β inhibitor 12 抑制 49.11% 25 μM 的 GSK-3β 的活性和37.11% 50 μM 的 GSK-3β 的活性。GSK-3β inhibitor 12 可用于研究有脂多糖诱导的帕金森。 | |||
T2261 |
IM-12
IM 12 |
GSK-3 | PI3K/Akt/mTOR signaling; Stem Cells |
IM-12 是一种 GSK-3β的抑制剂,其 IC50=53 nM,可提高 Wnt 信号传导。 | |||
T72048 |
CDK8-IN-12
|
GSK-3; CDK | Cell Cycle/Checkpoint; PI3K/Akt/mTOR signaling; Stem Cells |
CDK8-IN-12 是一种具有选择性、有效性和口服活性的 CDK8 抑制剂(Ki : 14 nM),是一种抗癌剂。CDK8-IN-12 对 GSK-3α、GSK-3β、PCK-θ 具有抑制作用,Ki 分别为 13 nM、4 nM、109 nM。CDK8-IN-12对 MV4-11 细胞显示出抗增殖活性。 | |||
T35560 |
SAR502250
|
||
SAR502250 is a potent, selective, ATP competitive, orally active and brain-penetrant inhibitor of GSK3, with an IC50 of 12 nM for human GSK-3β. SAR502250 displays antidepressant-like activity. SAR502250 can be used for the research of Alzheimer’s disease (AD)[1][2]. SAR502250 (0.01-1 μM; 36 h) attenuates the Aβ25-35-induced cell death in rat embryonic hippocampal neurons[2]. SAR502250 (1-100 mg/kg; a single p.o,) attenuates tau hyperphosphorylation in the cortex and spinal cord of transgenic mic... |